Global Medical REIT Inc To Go Ex-Dividend On December 20th, 2024 With 0.21 USD Dividend Per Share
December 4th (Eastern Time) - $Global Medical REIT Inc(GMRE.US)$ is trading ex-dividend on December 20th, 2024.Shareholders of record on December 20th, 2024 will receive 0.21 USD dividend per share
Global Medical REIT Keeps Quarterly Dividend at $0.21 a Share, Payable Jan. 8 to Shareholders of Record Dec. 20
Press Release: Global Medical REIT Inc. Board Declares 2024 Fourth Quarter Common and Preferred Dividends
JMP Securities Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating
Global Medical REIT Focuses on Growth and Stability
Global Medical REIT Inc | 10-Q: Q3 2024 Earnings Report
Global Medical REIT, Inc. (GMRE) Q3 2024 Earnings Call Transcript Summary
Global Medical REIT, Inc. (GMRE) Q3 2024 Earnings Call Transcript
Colliers Securities Maintains Global Medical REIT Inc(GMRE.US) With Buy Rating, Maintains Target Price $10
Strategic Growth and Financial Stability Support Buy Rating for Global Medical REIT
BMO Capital Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating, Maintains Target Price $10
Cautious Outlook on Global Medical REIT: Hold Rating Amid Financial Misses and Leverage Concerns
Express News | Global Medical REIT Inc: Qtrly Affo $0.22 per Share
Global Medical REIT Inc | 8-K: Global Medical REIT Announces Third Quarter 2024 Financial Results Year-to-Date Completed $80.3 Million in Acquisitions of Single Tenant Triple Net Medical Real Estate
Global Medical REIT FFO of $0.19 Misses by $0.01, Revenue of $34.26M Misses by $0.39M
Earnings Flash (GMRE) GLOBAL MEDICAL REIT Reports Q3 FFO $0.19
Express News | Global Medical REIT Q3 Adjusted Ffo USD 15.345 Million Vs. IBES Estimate USD 0.2
Berenberg Bank Initiates Global Medical REIT Inc(GMRE.US) With Buy Rating, Announces Target Price $11.75
Global Medical REIT Inc. Announces Dates for Third Quarter Earnings Release and Webcast
Prominent Wall Street short sellers: Investors should focus on defensive stocks earnings and wait for clearer employment data.
Morgan Stanley maintains a neutral stance on defensive stocks related to cyclical sectors in the economy, waiting for 'clearer' employment data. The bank believes employment data is a key driving factor for the year-end stock market.